17 February 2025
17 February 2025
The company raises $3.85m in seed funding for enhancing patience access, adherence and outcomes.
The investment is part of the government's commitment to enhance health infrastructure.
The expansion is part of the NHS Blood Borne Virus opt-out testing programme.
The acquisition is expected to be completed by the end of March 2025.
The initiative invites developers, consultancies and software firms to create and implement custom AI agents.
The partners aim to allow marketing teams to deploy and swiftly update digital health tools.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
